To further validate the disease-specificity of the three biomarkers, we examined serum levels for apoA-I, TTR and TF in 71 additional subjects that included normal (18), breast cancer (18), colon cancer (8), atherosclerosis (9), and early stage OC (18) (Fig. 2). Here, APOA1 is linked to colonic neoplasm.